CPMS | NEWSLETTER | ERN
HealthFlex
×
  • Home
  • The Network
    • Who We Are
    • Our Vision, Mission & Aim
    • Structure & Governance
    • Specialised Centres
    • Coordinators
    • Stakeholders & Supporters
    • Informative Materials
  • For Patients
    • Patient Board
    • Find a specialist centre
    • Patient Organisations
    • Patient Resources
    • Cross-border Healthcare
  • Expertise
    • Evaluation
    • Education Programme
    • Guidelines
    • UIMD Registry
    • Subnetworks
    • Work Packages
    • Transversal Activities
    • CPMS Support
    • Resources
  • News & Events
    • News
    • Events
  • Activities
    • Projects
    • Publications
  • Contact Us

Treatable neurometabolic diseases – Recordati Rare Diseases Foundation course 6-8 October 2022

Treatable neurometabolic diseases – Recordati Rare Diseases Foundation course 6-8 October 2022
EducationEducation for ProfessionalsEvents

The course on treatable neurometabolic diseases offered by Recordati Rare Diseases Foundation will take place in person from 6 to 8 October 2022 in Buenos Aires, Argentina. This course will review the current management of a range of inherited neurometabolic diseases and discuss what can be expected of treatment and what limitations remain.

Inherited neurometabolic disorders represent a rapidly growing group of genetic conditions and many of them are potentially treatable. To date, more than 1,450 disorders have been included in the International Classification of Inherited Metabolic Disorders (ICIMD) and most of them exhibit some degree of neurological involvement. Advances in genetics have revolutionized the way we understand, diagnose, and manage these inherited neurometabolic disorders. Dietary treatments, small molecules, enzyme replacement, organ transplantation and other biological approaches are now available as approved therapeutic options for many disorders. Gene therapy approaches are also in a very advanced stage of development. Early detection and early intervention in these diseases are invaluable in achieving better clinical outcomes, but also timely assessments using the appropriate tools are critical in terms to monitor and optimize treatment results. 

The target audience of this course involves neuroscientists, metabolic physicians, paediatricians, neurologists and child neurologists as well as laboratory neuroscientists, biochemical geneticists, biochemists and laboratory geneticists. Participants are expected to have prior knowledge about the field, practical experience with diagnosis treatment, and/or basic research is recommended.

 

The deadline for registration is the 26th of August 2022. 

For more information and registration, please visit the Recordati Rare Diseases Foundation website.  

Search

Last News & Events

  • EJP RD workshop – The Blood-Brain Barrier: current research and novel therapeutic crossing approaches
  • Patient representatives for Smith-Lemli-Opitz syndrome are looking for European families
  • Rare disease education in Europe – read the new publication
  • Rare Diseases events under the Czech EU Council Presidency
  • MetabERN Board meeting in Prague, 13-15 October 2022
  • EJP Research Mobility Fellowship is now open
  • First Italian National Meeting on Rare Inherited Metabolic Diseases in Adults
  • IRDiRC Diagnostic Scientific Committee Nomination Call

Activities

  • Publications and Guidelines
  • Unified Registry for Inherited Metabolic Disorders
  • Projects

Disclaimer

MetabERN is a European Reference Network (ERN) approved by the ERN Board of Member States.
The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
The content on this website represents the views of the network and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission or any other body of the European Union.

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

Newsletter

Sign up to the MetabERN newsletter

Follow us on Twitter

Tweets by @Metab_ERN

Search the website


Copyright ©2017-2021 all rights reserved
Previous Content

Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT